Using resistant starch to improve constipation
Effect of Resistant Starch on Symptom Improvement and Intestinal Microbiome in Patients With Functional Constipation
NA · Tongji Hospital · NCT06292949
This study is testing if eating resistant starch can help people with constipation feel better and improve their gut health without the side effects of regular laxatives.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Tongji Hospital (other) |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT06292949 on ClinicalTrials.gov |
What this trial studies
This clinical study investigates the effects of resistant starch on patients suffering from constipation, a common gastrointestinal disorder affecting a significant portion of the adult population. The study aims to explore how resistant starch can enhance gut microbiota and alleviate constipation symptoms without the adverse effects associated with traditional laxatives. Participants will consume resistant starch to assess its impact on their bowel movements and overall gastrointestinal health. The research is grounded in the understanding that diet plays a crucial role in gut health and microbiome composition.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with constipation according to the Roman IV criteria.
Not a fit: Patients with a history of colorectal tumors within the past two years will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a safe and effective dietary alternative for managing constipation.
How similar studies have performed: Other studies have shown promising results with dietary interventions targeting gut microbiota, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The clinical manifestation is constipation, which meets the diagnostic criteria of Roman IV constipation. Exclusion Criteria: * Colonoscopy excludes patients with colorectal tumors within one or two years
Where this trial is running
Wuhan, Hubei
- Department of Gastroenterology Tongji Hospital, Tongji Medical college, Huazhong University of Science and technology — Wuhan, Hubei, China (RECRUITING)
Study contacts
- Study coordinator: ping h Xie
- Email: hpxie@tjh.tjmu.edu.cn
- Phone: 86+13437187007
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Constipation, Resistant starch, Gut microbiota